Clinical Trials
3 trialsNCT02078102 2021-02-21
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Indiana University
Phase 2 Completed
NCT02003625 2020-05-18
Meloxicam vs Placebo for Mobilization
Massachusetts General Hospital
Phase 2 Completed
NCT02456363 2015-05-28
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Phase 2 Unknown